You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -200.6% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -4.6 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 8.5 | n/a |
Price / Book value | 4.1 |
Latest | Forecast | |
---|---|---|
Revenue | 90.3% | n/a |
PBT | 0.0% | n/a |
EPS | 0.0% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-12-31 | 1.70 | -3.51 | -17.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 1.16 | -6.95 | -27.00p | -14.8 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 2.40 | -10.54 | -32.00p | -7.5 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 4.57 | -8.90 | -28.00p | -6.5 | 0.0 | n/a | n/a | 0.0% |
Arecor Therapeutics shares tank on funding update Sharecast News | 10 Jun |
---|---|
Arecor subsidiary Tetris launching Ogluo in the Netherlands Sharecast News | 29 Feb |
Arecor appoints new commercial manager to Tetris subsidiary Sharecast News | 03 Jan |
Trading and Funding Update | 10-Jun-24 07:01 |
---|---|
Posting of 2023 Annual Report and Notice of AGM | 31-May-24 16:05 |
Grant of Options and PDMR Dealing | 23-May-24 07:01 |
Arecor to host company and KOL webinar today | 21-May-24 07:01 |
Positive headline results for AT278 clinical trial | 20-May-24 07:01 |